Clover Health (CLOV) Q2 FY26 earnings call

Clover Health delivered strong Q2 FY26 results, driven by market-leading MA membership growth and improved profitability, with H1 GAAP net income up $67 million. The recalculation to a 4.5-Star rating for PY2027 provides flexibility, but core confidence for 2027 is grounded in continued cohort maturation under Clover Assistant, which is expected to drive further earnings expansion. Management also highlighted new AI initiatives for back-office operations to streamline administrative functions and lower overhead.